---
schema_version: "secwatch.filing_event.v1"
accession: "0000078003-26-000053"
form_type: "8-K"
ticker: "PFE"
cik: "0000078003"
company_name: "PFIZER INC"
filed_at: "2026-05-05T23:59:59+00:00"
generated_at: "2026-05-14T23:39:32.966257+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Pfizer Q1 revenue $14.5B (+2% op); adj EPS $0.75 (-18%); reaffirms FY26 guidance

## Summary
- Revenue $14.45B, up 2% operationally; ex-COVID products grew 7% op; launched/acquired products up 22% op.
- Reported diluted EPS $0.47, adjusted $0.75 vs $0.92 in Q1 '25 (-18%).
- Reaffirmed FY26 revenue guidance $59.5-62.5B and adj EPS $2.80-3.00.
- Positive Phase 3 readouts for Elrexfio (RRMM), Padcev (MIBC), Talzenna+Xtandi, Lyme vaccine 73-75% efficacy.
- Exited ViiV Healthcare for $1.875B; Vyndamax patent settlement extends to 2031; GLP-1 collaboration in China for ecnoglutide.

## SEC filing metadata
- accession: 0000078003-26-000053
- form_type: 8-K
- ticker: PFE
- cik: 0000078003
- company_name: PFIZER INC
- filed_at: 2026-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/78003/000007800326000053/0000078003-26-000053-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/78003/000007800326000053/pfe-20260505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000078003-26-000053
- JSON: https://secwatch.observer/filing/0000078003-26-000053.json
- Plain text: https://secwatch.observer/filing/0000078003-26-000053.txt

## Key facts
- Earnings Releases
  PFIZER INC reported the first quarter of 2026 results: revenue $14,451, net income 2,687, EPS 0.47. Guidance reaffirmed.
  - Period: the first quarter of 2026
  - Revenue: $14,451
  - Net income: 2,687
  - EPS: 0.47
  - Guidance: reaffirmed
  - Result: reported results
  source text: rates (5) . Results for the first quarter of 2026 and 2025 (6) are summarized below. ($ in millions, except per share amounts) First-Quarter 2026 2025 % Change Revenues $ 14,451 $ 13,715 5% Reported (3) Net Income 2,687 2,967 (9%) Reported (3) Diluted EPS 0.47 0.52 (10%) Adjusted (4) Income 4,290 5,237 (18%) Adjusted (4) Diluted EPS 0.75 0.92 (18%)
  evidence_url: https://www.sec.gov/Archives/edgar/data/78003/000007800326000053/0000078003-26-000053-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.